Transactions
Jan. 30, 2001
Cooley Godward: DNA SCIENCES WRAPS DOUBLE HELIX AROUND FIRST OFFERING
DNA Sciences Inc. has filed for an initial public offering valued at $125 million. Fremont's DNA Sciences is a development-stage genetics discovery company. It plans to use the recent completion of the human genome sequence to determine the genetic basis for disease susceptibility, disease progression and people's response to drugs.
Fremont's DNA Sciences is a development-stage genetics discovery company. It plans to use the recent completion of the human genome sequence to determine the genetic basis for disease susceptibility, disease progression and people's response to drugs. The company is developing diagnostic tests fo...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In